Please assess the completion status of the following clinical trial:

Trial Title: A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Key Inclusion Criteria:~* Documented or suspected cUTI/AP with clinical signs and symptoms~* Normal kidney function defined as creatinine clearance (CLcr) of ≥60mL/min using Cockcroft-Gault formula~Key Exclusion Criteria:~* Acute bacterial prostatis, orchitis, epididymitis, or chronic bacterial prostatis~* Gross heanaturia requiring intervention other than study drug~* Urinary tract surgery within 7 days of randomization or during the study period~* A known nonrenal source of infection diagnosed within 7 days of randomization~* A corrected QT interval \> 440 msec~* History of hearing loss with onset before the age of 40 years, sensorineural hearing loss, or family history of hearing loss~* Pregnant or breastfeeding women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- plazomicin (10 mg/kg) (Type: EXPERIMENTAL): Patients received two intravenous (IV) infusions daily for 5 consecutive days: 10 milligrams per kilogram (mg/kg) plazomicin followed by placebo.
- plazomicin (15 mg/kg) (Type: EXPERIMENTAL): Patients received two IV infusions daily for 5 consecutive days: 15 mg/kg plazomicin followed by placebo.
- levofloxacin (Type: ACTIVE_COMPARATOR): Patients received two IV infusions daily for 5 consecutive days: placebo followed by 750 milligrams (mg) levofloxacin.

Based on this trial design, predict the completion outcome and termination type (if applicable).